I'm still labouring through the transcript, as time permits.
The first question that RP got was about the meeting/conference where Alizyme intend to present the full cetilistat data. The answer was:
A North American metabolic disease meeting, but I'm not saying we'll guarantee getting it in. We will submit an abstract early in the new year, probably for the ADA, but hopefully the editorial board will find the data interesting enough to include it in the programme.
ADA = American Diabetes Association
After a bit of looking around, it turns out that the deadline for abstracts is on the 9th of this month, with the meeting itself to be held from 9-13 June later this year.
There is an abstract archive for previous years' meetings, so with any luck Alizyme's abstract might be put online, assuming it's accepted, before the meeting is held.